StockTipsArenaBeta

BUY Cohance Lifesciences Limited — IDBI Capital

BUYCohance Lifesciences Limited
Cohance Lifesciences share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))7 Oct 2026via IDBI Capital Research Calls Telegram

Entry₹463Stated
Target₹490
Total upside +5.83% (call closed)
Stop loss₹451-2.59% risk
Exit₹4518 Oct 2026, 9:20 am
Stop-loss hit-2.59%
Follow IDBI Capital for new calls(26% target hit, 339 closed calls)Get alertsWatch COHANCE for new buy/sell callsGet alertsSee 193 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Oct, 7:49 pm IST
2 supporting0 opposing
Supports the BUY call (2)

Cohance Lifesciences rallies 20% after company names Umang Vohra as new Chairman and CEO

NewsGoogle News·3 Oct · 4d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·18 Aug · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Cohance Lifesciences

All analyst calls on Cohance Lifesciences

More from IDBI Capital

Every call and its outcome